Novozymes A/S (OTCMKTS:NVZMY) Rating Lowered to Sell at Citigroup

Citigroup cut shares of Novozymes A/S (OTCMKTS:NVZMY - Free Report) from a neutral rating to a sell rating in a report released on Thursday, Marketbeat reports.

Separately, Berenberg Bank upgraded Novozymes A/S to a "strong-buy" rating in a research report on Tuesday, September 24th.

Novozymes A/S Trading Down 1.6 %

NVZMY traded down $1.05 during trading on Thursday, hitting $65.95. The company's stock had a trading volume of 8,990 shares, compared to its average volume of 12,719. Novozymes A/S has a twelve month low of $38.83 and a twelve month high of $72.50. The business's fifty day simple moving average is $68.02 and its 200 day simple moving average is $62.78. The firm has a market capitalization of $30.88 billion, a price-to-earnings ratio of 41.74, a P/E/G ratio of 3.87 and a beta of 0.89.

Novozymes A/S Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, September 18th. Stockholders of record on Monday, September 9th were given a $0.1678 dividend. The ex-dividend date was Monday, September 9th. Novozymes A/S's dividend payout ratio (DPR) is presently 41.77%.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.